Zolpidem Tartrate
Product Images NDC 63304-159

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 63304-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ranbaxy Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure of Zolpidem Tartrate is shown, featuring a molecular diagram with two main components: the Zolpidem moiety on the left and the tartrate moiety on the right, indicating the common salt form of the drug.*

FDA Label Image

Label 10 mg (Image 02)

Label for Zolpidem Tartrate Tablets 10 mg by Ranbaxy Pharmaceuticals Inc. The label displays the NDC 63304-160-03, a 10-tablet count, and indicates that each tablet contains 10 mg of zolpidem tartrate. Instructions for use and storage conditions are included, along with a barcode and areas for lot and expiration information.*

FDA Label Image

Label 5mg (Label 5mg)

Zolpidem Tartrate 5 mg tablets packaging label by Ranbaxy Pharmaceuticals Inc. The label indicates 10 tablets, prescription only, with each tablet containing 5 mg of zolpidem tartrate as the active ingredient. Storage instructions and usage directions are also present, along with a barcode and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.